VOYA Investment Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.2K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $195K | Buy |
|
|||||
|
2023
Q2 | $289K | Sell |
|
|||||
|
2023
Q1 | $864K | Hold |
|
|||||
|
2022
Q4 | $1.68M | Hold |
|
|||||
|
2022
Q3 | $1.68M | Buy |
|
|||||
|
2022
Q2 | $314K | Buy |
|
|||||
|
2022
Q1 | $345K | Hold |
|
|||||
|
2021
Q4 | $291K | Buy |
|
|||||
|
2021
Q3 | $355K | Buy |
|
|||||
|
2021
Q2 | $301K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $17K | Hold |
|
|||||
|
2019
Q4 | $31K | Buy |
|
|||||
|
2019
Q3 | $15K | Hold |
|
|||||
|
2019
Q2 | $31K | Hold |
|
|||||
|
2019
Q1 | $85K | Hold |
|
|||||
|
2018
Q4 | $105K | Buy |
|
|||||
|
2018
Q3 | $165K | Hold |
|
|||||
|
2018
Q2 | $226K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $243K | Hold |
|
|||||
|
2017
Q3 | $254K | Buy |
|
|||||
|
2017
Q2 | $247K | Buy |
|